ECSP17025904A - RORC2 PYRROLOPYRIDINE MODULATORS REPLACED WITH METHYL AND TRIFLUOROMETHYL AND METHODS OF USE OF THE SAME - Google Patents
RORC2 PYRROLOPYRIDINE MODULATORS REPLACED WITH METHYL AND TRIFLUOROMETHYL AND METHODS OF USE OF THE SAMEInfo
- Publication number
- ECSP17025904A ECSP17025904A ECIEPI201725904A ECPI201725904A ECSP17025904A EC SP17025904 A ECSP17025904 A EC SP17025904A EC IEPI201725904 A ECIEPI201725904 A EC IEPI201725904A EC PI201725904 A ECPI201725904 A EC PI201725904A EC SP17025904 A ECSP17025904 A EC SP17025904A
- Authority
- EC
- Ecuador
- Prior art keywords
- methods
- methyl
- trifluoromethyl
- rorc2
- replaced
- Prior art date
Links
- XWIYUCRMWCHYJR-UHFFFAOYSA-N 1h-pyrrolo[3,2-b]pyridine Chemical compound C1=CC=C2NC=CC2=N1 XWIYUCRMWCHYJR-UHFFFAOYSA-N 0.000 title 1
- WZKSXHQDXQKIQJ-UHFFFAOYSA-N F[C](F)F Chemical group F[C](F)F WZKSXHQDXQKIQJ-UHFFFAOYSA-N 0.000 title 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical group [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 title 1
- 150000005255 pyrrolopyridines Chemical class 0.000 abstract 2
- 108091008773 RAR-related orphan receptors γ Proteins 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención proporciona pirrolopiridinas sustituidas con metilo y trifluorometilo, sus composiciones farmacéuticas, métodos para modular la actividad de RORγ y/o reducir la cantidad de IL-17 en un sujeto, y métodos de tratamiento de diversos trastornos médicos utilizando tales pirrolopiridinas y sus composiciones farmacéuticas.The present invention provides methyl and trifluoromethyl substituted pyrrolopyridines, their pharmaceutical compositions, methods of modulating RORγ activity and / or reducing the amount of IL-17 in a subject, and methods of treating various medical disorders using such pyrrolopyridines and their compositions. pharmaceuticals.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462055811P | 2014-09-26 | 2014-09-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP17025904A true ECSP17025904A (en) | 2017-09-29 |
Family
ID=58698667
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECIEPI201725904A ECSP17025904A (en) | 2014-09-26 | 2017-04-26 | RORC2 PYRROLOPYRIDINE MODULATORS REPLACED WITH METHYL AND TRIFLUOROMETHYL AND METHODS OF USE OF THE SAME |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR101992A1 (en) |
| EC (1) | ECSP17025904A (en) |
-
2015
- 2015-09-22 AR ARP150103045A patent/AR101992A1/en unknown
-
2017
- 2017-04-26 EC ECIEPI201725904A patent/ECSP17025904A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR101992A1 (en) | 2017-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2017002427A2 (en) | Methyl and trifluoromethyl substituted rorc2 pyrrolopyridine modulators and methods of use thereof | |
| ECSP20003147A (en) | CARBOXAMIDES AS MODULATORS OF SODIUM CHANNELS | |
| MX390120B (en) | SOMATOSTATIN MODULATORS AND THEIR USES. | |
| BR112019002538A2 (en) | use of a pharmaceutical composition comprising an allosteric modulator, use of a pharmaceutical composition comprising garboxadol or a pharmaceutically acceptable salt thereof, and pharmaceutical composition for parenteral administration | |
| CR20160047A (en) | RORC2 INHIBITORS AND THEIR METHODS OF USE | |
| MX2015003140A (en) | Formulations of enzalutamide. | |
| BR112016020618A8 (en) | antisense oligomer, pharmaceutical composition, and use of an antisense oligomer | |
| PE20151416A1 (en) | SPIRO-LACTAMA NMDA RECEIVER MODULATORS AND THEIR USES | |
| CO2018005315A2 (en) | Modulators of the interaction of sestrina-gator2 and its uses | |
| HUE060496T2 (en) | Therapeutic compounds and preparations for the treatment of social disorders and substance use disorders | |
| PT3723739T (en) | ISOXAZOLINE PARASITICIDE FORMULATIONS AND THEIR USE FOR THE TREATMENT OF BLEPHARITIS | |
| EA201791454A1 (en) | DRUG FORMS FOR TRANSDERMAL ADMINISTRATION | |
| DOP2018000034A (en) | COMBINATIONS OF AN OX40 ANTIBODY AND A TLR4 MODULATOR AND USES OF THE SAME | |
| MX2016014859A (en) | Pharmaceutical compositions comprising danirixin for treating infectious diseases. | |
| ECSP16086247A (en) | (S) -PIRLINDOLE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR USE IN MEDICINE | |
| ECSP16086232A (en) | (R) -PIRLINDOLE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR USE IN MEDICINE | |
| MX2017003949A (en) | NEW PEPTIDIC DERIVATIVES AND THEIR USES. | |
| MX2016005510A (en) | Nmda receptor modulators and prodrugs, salts, and uses thereof. | |
| CL2018002577A1 (en) | Physical form of a sgr modulator | |
| BR112018070603A2 (en) | phosfaplatin liquid formulations |